Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Minoxidil is effective in preventing hair loss after facelift surgery.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Older men with late-onset lupus have a higher mortality rate than women.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Francisco Camacho Martinez has made significant contributions to skin and sexually transmitted diseases, developed surgical techniques, but is concerned about patient survival rates and over-specialization in dermatology.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Nasolabial skin-fat grafts are good for nasal reconstruction with minimal scarring and no need for bolsters, but smoking may affect graft survival.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

Nanofat with stem cells is promising for treating hair loss, scars, and skin rejuvenation.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.